1. Home
  2. Labeler Index
  3. Leo Pharma Inc.
  4. 50222-501
  5. NDC Package Code: 50222-501-06 Taclonex

NDC Package 50222-501-06 Taclonex

Calcipotriene And Betamethasone Dipropionate Suspension Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50222-501-06
Package Description:
40 CARTON in 1 CASE / 1 BOTTLE in 1 CARTON / 60 g in 1 BOTTLE
Product Code:
50222-501
Proprietary Name:
Taclonex
Non-Proprietary Name:
Calcipotriene And Betamethasone Dipropionate
Substance Name:
Betamethasone Dipropionate; Calcipotriene Hydrate
Usage Information:
This product contains 2 drugs (betamethasone and calcipotriene) and is used to treat psoriasis of the scalp. Some brands of this medication are also used to treat psoriasis on the body. Betamethasone is a very strong corticosteroid drug that helps decrease the swelling, redness, and itching of the skin that occurs with this condition. Calcipotriene, which is also known as calcipotriol in other countries, is a form of vitamin D. It works by slowing down the growth of skin cells so that they do not build up into thickened, scaly skin patches. This medication should not be used if you have certain types of psoriasis (skin patches with pus-filled blisters, psoriasis with intense redness/shedding/oozing). Consult your doctor for more information. This product is not recommended for use in children because they may be at an increased risk for side effects. See also Side Effects and Precautions sections.
11-Digit NDC Billing Format:
50222050106
Billing Unit:
GM - Billing unit of "gram" is used when a product is measured by its weight.
NDC to RxNorm Crosswalk:
60 GM
NDC to RxNorm Crosswalk:
  • RxCUI: 833461 - calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension
  • RxCUI: 833461 - betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
  • RxCUI: 833461 - betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
  • RxCUI: 833463 - Taclonex Scalp (calcipotriene 0.005 % / betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) ) Topical Suspension
  • RxCUI: 833463 - betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion [Taclonex]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Leo Pharma Inc.
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • BETAMETHASONE DIPROPIONATE .5 mg/g
  • CALCIPOTRIENE HYDRATE 50 ug/g
    • Pharmacologic Class(es):
  • Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
  • Corticosteroid - [EPC] (Established Pharmacologic Class)
  • Vitamin D Analog - [EPC] (Established Pharmacologic Class)
  • Vitamin D - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA022185
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-01-2008
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50222-501-6610 PACKAGE in 1 BOX / 2 BOTTLE in 1 PACKAGE / 60 g in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50222-501-06?

    The NDC Packaged Code 50222-501-06 is assigned to a package of 40 carton in 1 case / 1 bottle in 1 carton / 60 g in 1 bottle of Taclonex, a human prescription drug labeled by Leo Pharma Inc.. The product's dosage form is suspension and is administered via topical form.

    Is NDC 50222-501 included in the NDC Directory?

    Yes, Taclonex with product code 50222-501 is active and included in the NDC Directory. The product was first marketed by Leo Pharma Inc. on June 01, 2008 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50222-501-06?

    The contents of this package are billed per "gm or gram", products billed per gram are products measured by weight. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 50222-501-06?

    The 11-digit format is 50222050106. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250222-501-065-4-250222-0501-06